Patent details

EP1345598 Title: The use of rosiglitazone for treating psychiatric disorders.

Basic Information

Publication number:
EP1345598
PCT Application Number:
PCT/GB/2001/005488
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP012712162
PCT Publication Number:
WO/2002/049626
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
The use of rosiglitazone for treating psychiatric disorders.
French Title of Invention:
L'utilisation de rosiglitazone pour le traitement de troubles psychiatriques.
German Title of Invention:
Die Verwendung von Rosiglitazon zur Behandlung von psychiatrischen Erkrankungen.
SPC Number:

Dates

Filing date:
12/12/2001
Grant date:
05/09/2007
EP Publication Date:
05/09/2007
PCT Publication Date:
27/06/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/09/2003
EP B1 Publication Date:
05/09/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/12/2009
Expiration date:
12/12/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/12/2001
 
 

Name:
SMITHKLINE BEECHAM PLC
Address:
980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/11/2007
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CHAPMAN Gayle, c/o GlaxoSmithKline
Address:
United Kingdom (GB)

2

Name:
VINSON Mary, c/o GlaxoSmithKline
Address:
United Kingdom (GB)

Priority

Priority Number:
0030845
Priority Date:
18/12/2000
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/427;
Filing date Document type Number of pages